Moody's Ratings (Moody's) has completed a periodic review of the ratings of Avient Corporation and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 7 March 2025 in which we reassessed the appropriateness of the ratings in the context of...
Moody's Ratings (Moody's) assigned a Ba3 rating to Avient Corporation's (Avient) proposed $650 million senior unsecured notes due in 2031. The net proceeds of the issuance and cash on hand will be used to refinance the company's existing $650 million senior unsecured notes due May 2025. The transa...
Moody's Ratings has completed a periodic review of the ratings of Avient Corporation and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 1 April 2024 in which Moody's reassessed the appropriateness of the ratings in the context of the ...
Moody's Investors Service (Moody's) has affirmed Avient Corporation's (Avient) Ba2 Corporate Family Rating (CFR) and Ba2-PD Probability of Default Rating (PDR). The Ba1 rating on the senior secured first lien term loan due 2029 and Ba3 rating on the existing senior unsecured notes were also affirmed...
Moody's Investors Service (Moody's) assigned a Ba1 rating to Avient Corporation's (Avient) $732 million senior secured first lien term loan refinancing due 2029. Proceeds will be used to refinance the company's existing balances on the $632.6 million ($427 outstanding) senior secured first lien term...
Moody's Investors Service ("Moody's") assigned a Ba1 rating to Avient Corporation's (Avient) proposed $500 million non-fungible term loan add-on due 2029 and Ba3 rating to the proposed $725 million senior unsecured notes due 2030. The Ba2 Corporate Family Rating (CFR), Ba2-PD Probability of Default ...
Moody's Investors Service ("Moody's") said that Avient Corporation's (Avient) Ba2 Corporate Family Rating (CFR) and stable outlook are not affected by the announcement on April 20 to acquire Royal DSM N.V.'s (A3 stable) Protective Materials business (Dyneema) for $1.485 billion in cash. Moody's view...
The independent financial analyst theScreener just lowered the general evaluation of AVIENT (US), active in the Commodity Chemicals industry. As regards its fundamental valuation, the title still shows 2 out of 4 possible stars. Its market behaviour, however, has slightly deteriorated and will be qualified as risky moving forward. theScreener considers that these new qualifications justify an overall rating downgrade to Slightly Negative. As of the analysis date March 18, 2022, the closing price...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.